Skip to content

Comparative analysis of TAP block combined with NSAID administration and epidural analgesia

Comparative analysis of TAP block combined with NSAID administration and epidural analgesia in early postoperative period: a randomized clinical trial - CATEPI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050827
Enrollment
120
Registered
2023-04-13
Start date
2019-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The study started in the beginning of January 2019 and ended in January 2021. The institutional review board approval was obtained for this study.

Interventions

1) the main group in which the TAP block was performed in early postoperative period (during the first 24 hrs). In addition, the patients of this group also received the intravenous administration of
TAP+NSAID&quot
. 2) the control group in which the epidural analgesia was used. As a local anesthetic, the 0.25% solution of bupivacaine was used. The 80 to 120 mg of bupivacaine solution were administered as a b
Epidural&quot

Sponsors

Pavlodar Branch of NCJSC "Semey Medical University"
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. adults 2. aged 18 to 75 3. male and female 4. ASA physical status of either I or II 5. written consent

Exclusion criteria

Exclusion criteria: 1. children 2. ASA status III, IV, V, VI 3. Refusal to sign the consent 4. dementia

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study was a comparison of an efficacy of TAP anesthesia to that of epidural anesthesia in managing the pain at 24 hrs after the laparoscopy surgery or laparotomy.

Secondary

MeasureTime frame
Secondary outcome measures included visual analog scores, satisfaction of patients and surgeons with anesthesia, hemodynamic criteria, oxygen saturation (SpO2), time of the transition of the patient from the inpatient to the ambulatory care and appearance of the adverse effects.

Countries

Asia(except Japan)

Contacts

Public ContactRinat Ashzhanov

Pavlodar Branch of NCJSC "Semey Medical University" Department of Emergency Medicine

mamyrova26@gmail.com+7(7182)55-28-54

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026